Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Legend Biotech Corp (LEGN US)
Watchlist
88
Analysis
Health Care
•
China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Innovent Biologics Inc
•
04 Apr 2022 07:57
Innovent Biologics Inc (1801.HK) - Capable of Surviving “this Winter”
After continuous pullback, investors may lose interest in Innovent. However, it still has investment value based on pipeline, resources, R&D and...
Xinyao (Criss) Wang
Follow
299 Views
Share
bearish
•
Shanghai Junshi Biosciences
•
07 Jul 2024 09:19
China Healthcare Weekly (July.7) - MNCs' Next Move In Licensing Deals, Topchoice, Junshi's Trouble
Investors should wait to see MNCs' next move before deciding on licensing deals. Topchoice's growth is positive but unit price per customer may...
Xinyao (Criss) Wang
Follow
394 Views
Share
bullish
•
Hutchmed China Ltd
•
19 Jun 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - Time to Reassess Valuation Prospects Despite the Pain Points
HUTCHMED’s 2024 full-year sales may once again exceed expectations. It's time to recalculate the peak sales of pipeline and the Company’s outlook....
Xinyao (Criss) Wang
Follow
201 Views
Share
bearish
•
Genscript Biotech
•
09 Jun 2024 16:00
China Healthcare Weekly (Jun.9) - New Akeso-Summit Deal, Jacobio Is a Good Bet, Genscript's Trouble
The new Akeso-Summit deal may pave the way for MNC to acquire Summit.Jacobio is a good target for potential M&A/license deal.Genscript faces US...
Xinyao (Criss) Wang
Follow
499 Views
Share
bullish
•
BeiGene
•
19 Feb 2024 08:55
BeiGene (6160.HK/BGNE.US/688235.CH) - 2023 Results Preview and Undervaluation Concerns
BeiGene's sluggish share price could be related to geopolitical conflicts/weak market sentiment. But there’s no need for US to sanction China's...
Xinyao (Criss) Wang
Follow
357 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x